Belpointe Asset Management LLC Raises Holdings in iShares Biotechnology ETF $IBB

Belpointe Asset Management LLC boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 83.6% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,789 shares of the financial services provider’s stock after purchasing an additional 5,825 shares during the quarter. Belpointe Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $1,846,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in IBB. Kornitzer Capital Management Inc. KS acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $884,000. Investment House LLC lifted its position in iShares Biotechnology ETF by 4.1% in the third quarter. Investment House LLC now owns 98,821 shares of the financial services provider’s stock valued at $14,267,000 after buying an additional 3,873 shares during the last quarter. Kanawha Capital Management LLC boosted its stake in iShares Biotechnology ETF by 0.9% during the third quarter. Kanawha Capital Management LLC now owns 8,845 shares of the financial services provider’s stock worth $1,277,000 after buying an additional 78 shares during the period. Westfuller Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF during the third quarter valued at about $76,000. Finally, Rossmore Private Capital purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at approximately $86,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.6%

NASDAQ:IBB opened at $176.90 on Wednesday. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $179.64. The company has a 50 day moving average price of $170.97 and a 200 day moving average price of $153.86.

iShares Biotechnology ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Tuesday, December 16th were issued a $0.1831 dividend. The ex-dividend date was Tuesday, December 16th. This represents a $0.73 annualized dividend and a dividend yield of 0.4%. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.